Timothy D. Mikulski
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Timothy D. Mikulski has a total of 12 co-authors. Here are the top co-authors by number of shared publications:
Adam Wilk
Department of Biology, William Paterson University, Wayne, New Jersey, USA
1 shared publicationBenjamin Williamson
Department of Biology, William Paterson University, Wayne, New Jersey, USA
1 shared publication- Christopher H. Heath
Department of Microbiology, PathWest Laboratory Medicine, Fiona Stanley Hospital , Murdoch, Western Australia
1 shared publication - David S. Perlin
Center for Discovery and Innovation, Hackensack Meridian Health
1 shared publication - Dianne J. Gardam
Department of Microbiology, PathWest Laboratory Medicine FSH Network, Fiona Stanley Hospital, Murdoch, Western Australia, Australia
1 shared publication Geselle Cancino-Prado
Department of Biology, William Paterson University, Wayne, New Jersey, USA
1 shared publication
Latest Publications
- Open Access
- 18 January 2022
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 66 (1) , e0162421
Impact of Erg11 Amino Acid Substitutions Identified in Candida auris Clade III Isolates on Triazole Drug Susceptibility
ERG11 sequencing of 28 Candida auris clade III isolates revealed the presence of concomitant V125A and F126L substitutions. Heterologous expression of Erg11-V125A/F126L in Saccharomyces cerevisiae led to reduced fluconazole and voriconazole susceptibilities.
- 18 January 2022
- Published by American Society for Microbiology in Antimicrobial Agents and Chemotherapy
- Vol. 66 (1) , e0162421
Open AccessImpact of Erg11 Amino Acid Substitutions Identified in Candida auris Clade III Isolates on Triazole Drug Susceptibility
ERG11 sequencing of 28 Candida auris clade III isolates revealed the presence of concomitant V125A and F126L substitutions. Heterologous expression of Erg11-V125A/F126L in Saccharomyces cerevisiae led to reduced fluconazole and voriconazole susceptibilities.